Resonance Health News September 2015

Resonance Health is happy to provide you with an update on our recent activity via our latest quarterly newsletter.

To read the newsletter please click here

Resonance Health Appoints New Distributor, KNS in Canada

Resonance Health is pleased to announce the appointment of KNS in Canada who will launch a local presence for FerriScan at the forthcoming 2015 Pan-Canadian Thalassemia Conference taking place in Toronto on September 25-26th

Read more

St Mary’s Hospital Celebrates 1000 FerriScans From Perth to Paddington!

St Mary’s Hospital has become one of the first hospitals in Europe to reach a milestone of providing 1000 FerriScans (the Gold Standard for measuring Liver Iron Concentration) for children and adult patients. 

Read more


We are excited to announce that the paediatric fatty liver disease study using HepaFat-Scan has now commenced in the USA. It is being run in collaboration with the prestigious children’s hospital, Children’s Healthcare of Atlanta. At the date of this release, approximately ten patients have already been recruited and had HepaFat-Scans completed for the study, which commenced last month. 

Read more

Entrepreneur of the Year Award - Western Region Technology Winner!

 Congratulations to our Chief Scientific Officer, Professor Tim St Pierre, for winning the Technology category of the Western Region EY Entrepreneur of the Year™ award on behalf of Resonance Health!

Read more

Conference Update: China Symposium on NAFLD in Shanghai

The symposia on Non-alcoholic Fatty Liver Disease (NAFLD) in Shanghai was co-organised by the China Medical Association and Zhongshan Hospital Fudan University, chaired by Prof Gao Xin.

Read more